SHELF BRACKET ASSEMBLY

A shelf bracket assembly mounted upright on a vertically disposed shelf has: a load cell; an anchor; and a cantilever supporting a shelf panel. The cantilever projects from the shelf upright in a substantially horizontal direction. The cantilever has a vertically disposed frame or a vertically disposed metal plate and a mount for the load cell. The load cell has a monolithic measuring body that has: a force-supporting section; a force-introduction section; and a linkage section between the force-supporting section and the force-introduction section. The force-supporting section of the monolithic measuring body is laterally attached to the mount. The monolithic measuring body has at least one mounting hole through which the monolithic measuring body is attached to the mount with a screw extending horizontally through the monolithic measuring body. 1. A shelf bracket assembly capable of being mounted upright on a vertically disposed shelf , the shelf bracket assembly comprising:at least one load cell;an anchor; anda cantilever configured to support a shelf panel,wherein, in a condition where the shelf bracket assembly is mounted upright on the shelf, the cantilever projects from the shelf upright in a substantially horizontal direction,wherein the cantilever comprises a vertically disposed frame or a vertically disposed metal plate,wherein the cantilever comprises at least one mount for the at least one load cell, a force-supporting section;', 'a force-introduction section; and', 'a linkage section disposed between the force-supporting section and the force-introduction section,, 'wherein the at least one load cell comprises a monolithic measuring body comprisingwherein the force-supporting section of the monolithic measuring body is laterally attached to the mount, andwherein the monolithic measuring body has at least one mounting hole through which the monolithic measuring body is attached to the mount with a screw extending horizontally through the monolithic ...

SHELF BRACKET ASSEMBLY

A shelf bracket assembly is mounted on a vertically disposed shelf upright, and has: at least one weighing device; an anchoring device; and a cantilever for supporting a shelf panel. In a condition where the shelf bracket assembly is mounted on the shelf upright, the cantilever projects from the shelf upright in a substantially horizontal direction. The cantilever has a vertically disposed metal plate. In a Cartesian coordinate system, an extent of the cantilever in a horizontal plane defines a Y-direction, a vertical direction defines a Z-direction, and a direction perpendicular to the Y-direction and the Z-direction defines an X-direction. The at least one weighing device includes: a force-introduction section; a linkage section; and a force-supporting section. The linkage section comprises two weighing plates extending horizontally and parallel to each other. The force-supporting section and the force-introduction section are at least partially formed of vertically extending metal plates. 1. A shelf bracket assembly capable of being mounted on a vertically disposed shelf upright the shelf bracket assembly comprising:at least one weighing device;an anchoring device; anda cantilever for supporting a shelf panel,wherein, in a condition where the shelf bracket assembly is mounted on the shelf upright, the cantilever projects from the shelf upright in a substantially horizontal direction,wherein the cantilever comprises a vertically disposed metal plate,wherein in a Cartesian coordinate system, an extent of the cantilever in a horizontal plane defines a Y-direction, a vertical direction defines a Z-direction, and a direction perpendicular to the Y-direction and the Z-direction defines an X-direction, a force-introduction section;', 'a linkage section; and', 'a force-supporting section,, 'wherein the at least one weighing device compriseswherein the linkage section comprises two weighing plates extending horizontally and parallel to each other, andwherein the force- ...

LOAD CELL

A load cell has a monolithic measuring body. The monolithic measuring body has: a force-supporting section; a force-introduction section; and a linkage section disposed between the force-supporting section and the force-introduction section. The monolithic measuring body has a longitudinal axis between a force-supporting-side axial end and a force-introduction-side axial end. The longitudinal axis is configured to extend in a horizontal direction. The monolithic measuring body further has, in the force-supporting section, at least one mounting hole for attachment of the monolithic measuring body, the axis of the at least one mounting hole extending in the horizontal direction. At least one strain gauge is configured to sense tensile or compressive deformation of the monolithic measuring body and is in a region of the linkage section on a top side or a bottom side of the monolithic measuring body, the at least one strain gauge being oriented in the horizontal direction. 1. A load cell comprising: a force-supporting section;', 'a force-introduction section; and', 'a linkage section disposed between the force-supporting section and the force-introduction section,', 'the monolithic measuring body having a longitudinal axis between a force-supporting-side axial end and a force-introduction-side axial end,', 'the longitudinal axis being configured to extend in a horizontal direction,', 'the monolithic measuring body further comprising, in the force-supporting section, at least one mounting hole for attachment of the monolithic measuring body, the axis of the at least one mounting hole extending in the horizontal direction; and', 'at least one strain gauge configured to sense tensile or compressive deformation of the monolithic measuring body and disposed in a region of the linkage section on a top side or a bottom side of the monolithic measuring body, the at least one strain gauge being oriented in the horizontal direction., 'a monolithic measuring body comprising2. The ...

2 (3,4 Dimethyl-coumarin 7 yl) oxy alkylcarboxylic acid derivatives and process for their preparation

DEVICE FOR MOVING MOVING ARROWS AND THEIR USE

Bei einer Vorrichtung zum Fuehren von durch antreibbare Foerdermittel bewegten Bogen aus Papier oder anderen blattfoermigen Werkstoffen, die ein Richtlineal und eine parallel zum Richtlineal verlaufende Kugelleiste aufweist, deren einzelne Kugeln kraftschluessig auf den Foerdermitteln und den darueber bewegten Bogen aufliegen, soll die Anlaufkraftkomponente der gefoerderten Bogen zum Richtlineal hin sowie die Umfangsgeschwindigkeit und Drehrichtung der Kugeln moeglichst konstant gehalten und dadurch die Gefahr des Abwanderns der Bogen vom Richtlineal verringert werden. Dies wird erfindungsgemaesz dadurch erreicht, dasz auf der den Foerdermitteln abgewandten Seite der Kugeln unter der Einwirkung einer Federkraft stehende drehbare Lastelemente angeordnet sind, die kraftschluessig die Oberflaeche der ihnen zugeordneten Kugeln beruehren. Die Vorrichtung wird vorzugsweise zum Fuehren, Ausrichten und Niederhalten von Falzbogen in Falz- und Druckmaschinen, Foerdertischen und Bogenanlegern verwendet. Fig. 1 In a device for guiding driven by drivable Foerdermittel sheet of paper or other Blattfoermigen materials, which has a straightedge and a parallel to the straightedge ball bar whose individual balls lie non-positively on the Foerdermitteln and the bow over it, the starting force component of the gefoerderten arc towards the straightedge and the peripheral speed and direction of rotation of the balls kept as constant as possible, thereby reducing the risk of migration of the sheets from the straightedge. This is achieved according to the invention by the fact that rotatable load elements are arranged on the side of the balls facing away from the conveying means under the action of a spring force, which contact the surface of the balls assigned to them in a force-locking manner. The apparatus is preferably used for guiding, aligning and holding folded sheets in folding and printing machines, conveyor tables and sheet feeders. Fig. 1

Device for guiding moving sheets as well as their use

Shelf bracket assembly

A shelf bracket assembly mounted upright on a vertically disposed shelf has: a load cell; an anchor; and a cantilever supporting a shelf panel. The cantilever projects from the shelf upright in a substantially horizontal direction. The cantilever has a vertically disposed frame or a vertically disposed metal plate and a mount for the load cell. The load cell has a monolithic measuring body that has: a force-supporting section; a force-introduction section; and a linkage section between the force-supporting section and the force-introduction section. The force-supporting section of the monolithic measuring body is laterally attached to the mount. The monolithic measuring body has at least one mounting hole through which the monolithic measuring body is attached to the mount with a screw extending horizontally through the monolithic measuring body.

DEVICE FOR GUIDING MOVING BOWS AND THEIR USE

Use of microtubule stabilizing compounds for the treatment of lesions of cns axons

Schneidegeraet fuer Haushaltszwecke

Use of microtubule stabilizing compounds for the treatment of lesions of cns axons

The present invention provides a use of one or more microtubule stabilizing compounds for the preparation of a pharmaceutical composition for the treatment of lesions of CNS axons wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto, whereby the one or more compound(s) is/are selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164, borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B). Furthermore, the invention provides a method for the treatment of lesions of CNS axons the method comprising the step of administering to a patient in the need thereof a pharmaceutical composition comprising (i) one or more microtubule stabilizing compounds selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164,' borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B) and, optionally, (ii) further comprising suitable formulations of carrier, stabilizers and/or excipients, wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto.

Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons

The present invention provides a use of one or more microtubule stabilizing compounds for the preparation of a pharmaceutical composition for the treatment of lesions of CNS axons wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto, whereby the one or more compound(s) is/are selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164, borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B). Furthermore, the invention provides a method for the treatment of lesions of CNS axons the method comprising the step of administering to a patient in the need thereof a pharmaceutical composition comprising (i) one or more microtubule stabilizing compounds selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164,′ borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B) and, optionally, (ii) further comprising suitable formulations of carrier, stabilizers and/or excipients, wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto.

Use of microtubule stabilizing compounds for the treatment of lesions of cns axons

The present invention provides a use of one or more microtubule stabilizing compounds for the preparation of a pharmaceutical composition for the treatment of lesions of CNS axons wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto, whereby the one or more compound(s) is/are selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164, borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B). Furthermore, the invention provides a method for the treatment of lesions of CNS axons the method comprising the step of administering to a patient in the need thereof a pharmaceutical composition comprising (i) one or more microtubule stabilizing compounds selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164,' borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B) and, optionally, (ii) further comprising suitable formulations of carrier, stabilizers and/or excipients, wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto.

Use of microtubule stabilizing compounds for the treatment of lesions of CNS axons

Use of microtubule stabilizing compounds for the treatment of lesions of cns axons

The present invention provides a use of one or more microtubule stabilizing compounds for the preparation of a pharmaceutical composition for the treatment of lesions of CNS axons wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto, whereby the one or more compound(s) is/are selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164, borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B). Furthermore, the invention provides a method for the treatment of lesions of CNS axons the method comprising the step of administering to a patient in the need thereof a pharmaceutical composition comprising (i) one or more microtubule stabilizing compounds selected from the group consisting of taxanes, epothilones, laulimalides, sesquiterpene lactones, sarcodictyins, diterpenoids, peloruside A, discodermolide, dicoumarol, ferulenol, NSC12983, taccalonolide A, taccalonolide E, Rhazinilam, nordihydroguaiaretic acid (NDGA), GS-164,' borneol esters, Synstab A, Tubercidin and FR182877 (WS9885B) and, optionally, (ii) further comprising suitable formulations of carrier, stabilizers and/or excipients, wherein the pharmaceutical composition is administered locally directly into the lesion or immediately adjacent thereto.

Regalkonsole

Die vorliegende Erfindung betrifft eine Regalkonsole mit mindestens einer Wägevorrichtung. Die Regalkonsole ist geeignet zum befestigt werden in einer vertikal angeordneten Regalschiene. Dazu umfasst die Regalkonsole eine Verankerungsvorrichtung. Die Regalkonsole umfasst ferner einen Ausleger zum Tragen eines Regalfachbodens. In einem Zustand, in dem die Regalkonsole in einer Regalschiene befestigt ist, steht der Ausleger in einer im Wesentlichen horizontalen Richtung von der Regalschiene ab. In einer Ausführungsform ist der Ausleger durch ein vertikal angeordnetes Blech gebildet ist. In einem kartesischen Koordinatensystem definiert die Ausdehnung des Auslegers in der horizontalen Ebene eine Y-Richtung, die vertikale Richtung definiert eine Z-Richtung und die senkrecht zur Y-Richtung und Z-Richtung stehende Richtung definiert eine X-Richtung. Die mindestens eine Wägevorrichtung weist einen Krafteinleitungsabschnitt, einen Gelenkabschnitt und einen Kraftaufnahmeabschnitt auf. Der Gelenkabschnitt besteht aus zwei horizontal und parallel zueinander verlaufenden Wiegeblechen. Der Kraftaufnahmeabschnitt und der Krafteinleitungsabschnitt bestehen zumindest teilweise aus vertikal verlaufenden Blechen.

alpha (p Chlor) phenoxy isobutter saure eckige Klammer auf 2 (p Chlor) 'phenoxy 2 methyl eckige Klammer zu propylester und Verfahren zur Herstel lung derselben